Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01993017 · ClinicalTrials.gov registry record · NA
Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost Outcomes
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 1,501
- Enrollment target
NCT01993017 is a NA study that has completed, run by Columbia University. The registered enrollment target is 1,501 participants.
The verdict
NCT01993017, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,501 participants
- Enrollment target
Study Summary
The purpose of this study is to examine, in a randomized controlled trial, the benefits and costs of the American Heart Association's (AHA) advisory for depression screen and treatment of post-acute coronary syndrome patients.
Interventions
- OTHER No intervention
- OTHER Standard Care
- OTHER Cognitive Behavioral Therapy (CBT)
- DRUG Antidepressant Medication
- OTHER Depressive symptom screener
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,501 participants |
| Start Date | 2013-11 |
| Est. Completion | 2019-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01993017
The ClinicalTrials.gov registry entry for NCT01993017 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,501 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which No intervention is the first listed.
NCT01993017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01993017 about?
NCT01993017 is a clinical study titled "Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost Outcomes". The purpose of this study is to examine, in a randomized controlled trial, the benefits and costs of the American Heart Association's (AHA) advisory for depression screen and treatment of post-acute coronary syndrome patients.
What is the current status of trial NCT01993017?
This trial is currently completed. It is a NA study. The enrollment target is 1,501 participants. The study started on 2013-11. Estimated completion is 2019-07-31.
What interventions are being tested in trial NCT01993017?
The interventions under investigation include: No intervention (OTHER), Standard Care (OTHER), Cognitive Behavioral Therapy (CBT) (OTHER), Antidepressant Medication (DRUG), Depressive symptom screener (OTHER).
Who is sponsoring clinical trial NCT01993017?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.